Ultragenyx Says Week 96 Phase 3 Data On GENGLYCOS In Glycogen Storage Disease Type Ia Show 61% Mean Reduction In Daily Cornstarch Intake, With 33% Of Treatment Group And 42% Of Crossover Group Eliminating Nighttime Dosing

뉴스 본문을 불러오고 있어요.

Ultragenyx Says Week 96 Phase 3 Data On GENGLYCOS In Glycogen Storage Disease Type Ia Show 61% Mean Reduction In Daily Cornstarch Intake, With 33% Of Treatment Group And 42% Of Crossover Group Eliminating Nighttime Dosing | 웨이프 WAPE

Ultragenyx Says Week 96 Phase 3 Data On GENGLYCOS In Glycogen Storage Disease Type Ia Show 61% Mean Reduction In Daily Cornstarch Intake, With 33% Of Treatment Group And 42% Of Crossover Group Eliminating Nighttime Dosing

기사 요약

관련 종목

댓글 —